» Articles » PMID: 28231775

Effects of Mindfulness-based Interventions on Biomarkers in Healthy and Cancer Populations: a Systematic Review

Overview
Publisher Biomed Central
Date 2017 Feb 25
PMID 28231775
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Only a small number of articles have investigated the relationship between mindfulness-based interventions (MBIs) and biomarkers. The aim of this systematic review was to study the effect of MBIs on specific biomarkers (cytokines, neuropeptides and C-reactive protein (CRP)) in both healthy subjects and cancer patients.

Methods: A search was conducted using PubMed, EMBASE, PsycINFO and the Cochrane library between 1980 and September 2016.

Results: A total of 13 studies with 1110 participants were included. In the healthy population, MBIs had no effect on cytokines, but were found to increase the levels of the neuropeptide insulin-like growth factor 1 (IGF-1). With respect to neuropeptide Y, despite the absence of post-intervention differences, MBIs may enhance recovery from stress. With regard to CRP, MBIs could be effective in lower Body Mass Index (BMI) individuals. In cancer patients, MBIs seem to have some effect on cytokine levels, although it was not possible to determine which specific cytokines were affected. One possibility is that MBIs might aid recovery of the immune system, increasing the production of interleukin (IL)-4 and decreasing interferon gamma (IFN-γ).

Conclusions: MBIs may be involved in changes from a depressive/carcinogenic profile to a more normalized one. However, given the complexity and different contexts of the immune system, and the fact that this investigation is still in its preliminary stage, additional randomized controlled trials are needed to further establish the impact of MBI programmes on biomarkers in both clinical and non-clinical populations.

Citing Articles

Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy Participants.

Liu Y, Li J, Lyu J, Howard L, Sibley A, Starr M Cancer Epidemiol Biomarkers Prev. 2024; 34(1):93-99.

PMID: 39400560 PMC: 11717622. DOI: 10.1158/1055-9965.EPI-24-0644.


The Effectiveness of Mindfulness in the Treatment of Methamphetamine Addiction Symptoms: Does Neuroplasticity Play a Role?.

Chmiel J, Malinowska A, Rybakowski F, Leszek J Brain Sci. 2024; 14(4).

PMID: 38671972 PMC: 11047954. DOI: 10.3390/brainsci14040320.


The impact of a virtual mind-body program on symptoms of depression and anxiety among international English-speaking adults with neurofibromatosis.

McDermott K, Bakhshaie J, Brewer J, Vranceanu A Am J Med Genet A. 2024; 194(6):e63543.

PMID: 38318960 PMC: 11846071. DOI: 10.1002/ajmg.a.63543.


The Impact of Mindfulness on Functional Brain Connectivity and Peripheral Inflammation in Breast Cancer Survivors with Cognitive Complaints.

Melis M, Schroyen G, Blommaert J, Leenaerts N, Smeets A, Van der Gucht K Cancers (Basel). 2023; 15(14).

PMID: 37509292 PMC: 10377401. DOI: 10.3390/cancers15143632.


Only Small Effects of Mindfulness-Based Interventions on Biomarker Levels of Inflammation and Stress: A Preregistered Systematic Review and Two Three-Level Meta-Analyses.

Grasmann J, Almenrader F, Voracek M, Tran U Int J Mol Sci. 2023; 24(5).

PMID: 36901875 PMC: 10003032. DOI: 10.3390/ijms24054445.


References
1.
Cuijpers P, Sijbrandij M, Koole S, Huibers M, Berking M, Andersson G . Psychological treatment of generalized anxiety disorder: a meta-analysis. Clin Psychol Rev. 2014; 34(2):130-40. DOI: 10.1016/j.cpr.2014.01.002. View

2.
Jain F, Walsh R, Eisendrath S, Christensen S, Cahn B . Critical analysis of the efficacy of meditation therapies for acute and subacute phase treatment of depressive disorders: a systematic review. Psychosomatics. 2015; 56(2):140-52. PMC: 4383597. DOI: 10.1016/j.psym.2014.10.007. View

3.
Creswell J, Taren A, Lindsay E, Greco C, Gianaros P, Fairgrieve A . Alterations in Resting-State Functional Connectivity Link Mindfulness Meditation With Reduced Interleukin-6: A Randomized Controlled Trial. Biol Psychiatry. 2016; 80(1):53-61. DOI: 10.1016/j.biopsych.2016.01.008. View

4.
Oken B, Fonareva I, Haas M, Wahbeh H, Lane J, Zajdel D . Pilot controlled trial of mindfulness meditation and education for dementia caregivers. J Altern Complement Med. 2010; 16(10):1031-8. PMC: 3110802. DOI: 10.1089/acm.2009.0733. View

5.
Matchim Y, Armer J, Stewart B . Mindfulness-based stress reduction among breast cancer survivors: a literature review and discussion. Oncol Nurs Forum. 2011; 38(2):E61-71. DOI: 10.1188/11.ONF.E61-E71. View